Company performance
Add to research
Current Price
as of Jul 08, 2025$2.20
P/E Ratio
N/A
Market Cap
$335.64M
Description
Add to research
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.
Metrics
Add to research
Overview
- HQCary, NC
- SectorHealth Technology
- IndustryBiotechnology
- TickerHRTX
- Price$2.2+2.33%
Trading Information
- Market cap$335.64M
- Float99.05%
- Average Daily Volume (1m)1,570,237
- Average Daily Volume (3m)1,569,305
- EPS-$0.05
Company
- Revenue$148.52M
- Rev growth (1yr)12.21%
- Net income$2.64M
- Gross margin78.26%
- EBITDA margin9.52%
- EBITDA$3.70M
- EV$559.80M
- EV/Revenue3.77
- P/EN/A
- P/S2.92
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account